Peter A. Voss v. HHS - Tdap, Guillain-Barré syndrome (2017)

Peter A. Voss filed a petition on August 15, 2016, seeking compensation under the National Vaccine Injury Compensation Program.

He alleged that he suffered from Guillain-Barré syndrome (GBS) as a result of receiving a Tetanus-diphtheria-acellular-pertussis (Tdap) vaccine on January 6, 2015. Mr.

Voss further alleged that he experienced residual effects from the condition for more than six months. The respondent, the Secretary of Health and Human Services, denied that the Tdap vaccine caused Mr.

Voss's GBS or any other injury. Despite maintaining their respective positions, both parties agreed to settle the case through a stipulation filed on June 27, 2017.

Special Master Brian H. Corcoran reviewed the stipulation and found it to be reasonable, adopting it as the decision of the court.

The stipulation awarded Mr. Voss a lump sum of $150,000.00, payable by check, as compensation for all damages.

This decision was issued on June 28, 2017. The public decision was designated "not to be published" but was posted on the Court of Federal Claims’s website in accordance with the E-Government Act of 2002, with parties having the option to request redaction of confidential information.

Petitioner's counsel was Scott B. Taylor of Urban and Taylor, S.C., and respondent's counsel was Sarah C.

Duncan of the U.S. Department of Justice.

The public decision does not describe the onset of symptoms, specific medical tests, treatments, or the medical expert witnesses involved.